Home > Insider Trading > Filing (0001237899-14-000053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226689	Neil Stahl	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Research And Development S	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-08-06	35,000	$21.25	48,527	No	4	M	Direct
Common Stock	Disposition	2014-08-06	2,212	$336.11	46,315	No	4	F	Direct
Common Stock	Disposition	2014-08-06	18,301	$336.11	28,014	No	4	F	Direct
Common Stock	Disposition	2014-08-07	624	$340.39	27,390	No	4	S	Direct
Common Stock	Disposition	2014-08-07	117	$341.03	27,273	No	4	S	Direct
Common Stock	Disposition	2014-08-08	1,900	$340.60	25,373	No	4	S	Direct
Common Stock	Disposition	2014-08-08	200	$341.00	25,173	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-08-06	35,000	$0.00	35,000	$21.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
45,295		2019-12-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	by GRAT
Common Stock	10,864	Indirect	by GRAT
Common Stock	5,568	Indirect	By 401(k) Plan

Footnotes

Represents volume-weighted average price of sales of 624 shares of Company stock on August 7, 2014 at prices ranging from $340.00 to $340.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 7, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 8, 2014 at prices ranging from $340.00 to $340.995. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012.